Manganese-induced apoptosis through the ROS-activated JNK/FOXO3a signaling pathway in CTX cells, a model of rat

Wan-He Li1, Zheng-Ting-Yan Xiang2, An-Xin Lu3

  • 1Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, School of Pubilc Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; State Key Laboratory of Bioreactor Engineering and Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China; Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Insights

Manganese (Mn) overexposure triggers neurotoxicity by activating ROS-dependent JNK/FOXO3a signaling, leading to astrocyte apoptosis. Inhibiting ROS or JNK reduces Mn-induced cell death, revealing therapeutic targets.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Manganese (Mn) is essential but toxic at high levels, causing neurotoxicity.
  • The role of reactive oxygen species (ROS)-activated JNK/FOXO3a signaling in Mn neurotoxicity is not fully understood.

Purpose of the Study:

  • To investigate the modulation of the ROS-activated JNK/FOXO3a pathway in manganese-induced apoptosis in rat brain astrocytes (CTX cells).

Main Methods:

  • CTX cells were exposed to varying Mn concentrations.
  • Assessed cell viability, apoptosis-related proteins (Bcl-2, Bax, Cleaved-Caspase3), ROS levels, and JNK/FOXO3a phosphorylation.
  • Used N-acetyl-L-cysteine (NAC) to deplete ROS and SP600125 to inhibit JNK.

Main Results:

  • Mn exposure decreased CTX cell viability and Bcl-2 expression while increasing Bax and Cleaved-Caspase3.
  • Mn elevated ROS and phosphorylated JNK, but decreased phosphorylated FOXO3a.
  • NAC and SP600125 treatment attenuated Mn-induced pathway activation and apoptosis.

Conclusions:

  • Mn induces apoptosis in astrocytes via ROS generation and subsequent JNK/FOXO3a pathway dysregulation.
  • This study elucidates Mn neurotoxic mechanisms and suggests potential therapeutic targets for Mn exposure.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K